Joselle M. Cook

Hematology

200 1st St SW
Rochester, MN 55905

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 97 publications

Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis.

Diagnostic Accuracy of Fat Pad Sampling and Bone Marrow Biopsy for AL Amyloidosis: A Systematic Review and Meta-Analysis.

Journal: Blood advances

Published: July 08, 2026

Complementary Role of Whole-Body MRI and CT in Hematologic Malignancies and Bone Marrow Disorders.

Complementary Role of Whole-Body MRI and CT in Hematologic Malignancies and Bone Marrow Disorders.

Journal: Journal of computer assisted tomography

Published: June 08, 2026

Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

Journal: American journal of hematology

Published: May 30, 2026

Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

Risk of AL Amyloidosis is Associated with Degree of Free Light Chain Elevation and Duration of Exposure.

Journal: Research square

Published: April 17, 2026

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Early Treatment Failure in Patients Receiving Ciltacabtagene-Autoleucel for Relapsed/Refractory Multiple Myeloma.

Journal: American journal of hematology

Published: March 31, 2026

Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

Self-Reported Geriatric Impairments and Treatment Toxicity in Older Patients with Multiple Myeloma-A Single Center Prospective Study.

Journal: Blood advances

Published: March 31, 2026

Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.

Patterns of Progression and Clinical Outcomes After First Progression in Patients With Primary Plasma Cell Leukemia.

Journal: American journal of hematology

Published: March 31, 2026

Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma.

Biomarkers of Cellular Senescence and their Association with Frailty, Clinical Outcomes, and Survival in Multiple Myeloma.

Journal: Research square

Published: March 27, 2026

High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

High prevalence of iron deficiency among daratumumab-treated newly diagnosed multiple myeloma patients.

Journal: British journal of haematology

Published: March 23, 2026

Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

Predictors of post-transplant measurable residual disease negativity and impact on clinical outcomes in multiple myeloma.

Journal: Blood advances

Published: March 06, 2026

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

Characteristics and outcomes of secondary hematological malignancies following autologous stem cell transplantation for multiple myeloma.

Journal: Blood cancer journal

Published: January 15, 2026

Determinants of gastrointestinal disease burden and survival in systemic AL amyloidosis.

Determinants of gastrointestinal disease burden and survival in systemic AL amyloidosis.

Journal: Blood advances

Published: January 14, 2026

Showing 1-12 of 97

Last Updated: 09/26/2026